SBIR/STTR Research Award
NONINVASIVE DEVICE FOR SEALING VASCULAR ACCESS PUNCTURES
Award amount
$130,965Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- THERUS CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Verbatim from Applicant's Abstract): In the United States alone,
over 2.5 million diagnostic catheterization procedures are performed annually.
These procedures are not performed without risk, and a number of complications
such as hematoma, pseudoaneurysm, and arteriovenous fistula occur that are
responsible for considerable morbidity and some mortality. In addition, many of
these complications result in considerable increases in hospital stays and
their associated costs. A number of commercial devices to seal catheter wounds
have been developed and are being marketed; however, these devices have
drawbacks-they lack effectiveness, are too expensive, or are diffcult to use.
In our preliminary studies, we demonstrated that High Intensity Focused
Ultrasound (HITU) can be successfully used to induce hemostasis of catheter
wounds in large laboratory animals. Because ultrasound can be applied
transcutaneously, the use of HITU for catheter wound closing has considerable
promise. In this Phase I application, we propose to (1) develop a device that
would use ultrasound imaging and HITU to produce noninvasive catheter wound
sealing, (2) test this device on laboratory animals, and (3) investigate any
collateral bioeffects of this procedure. The Phase II study would utilize these
results to build a model for human use. In Phase III, human clinical trals
would be performed.
PROPOSED COMMERCIAL APPLICATION:
More than 7,000,000 percutaneous catheterization procedures are performed each year,
each leaving behind an arterial puncture that must be sealed. The envisioned product would
facilitate a rapid, noninvasive means for accomplishing this task. If successful, the product
would become a standard of practice because it speeds sealing, increases catheterization
laboratory throughput, reduces overnight hospitalizations, and does not require interruption
of the patients anticoagulation therapy.
Technology keywords
Not reported